US Bariatric Surgery Devices Market Analysis

US Bariatric Surgery Devices Market Executive Summary

The US Bariatric Surgery Devices Market is at around $1117.2 Mn in 2023 and is projected to reach $1392.8 Mn in 2030, exhibiting a CAGR of 3.2% during the forecast period 2023-2030.

Gastric bypass and other types of weight-loss surgery, also called bariatric or metabolic surgery, this involve making changes to your digestive system to help you lose weight. Bariatric surgery is done when diet and exercise haven't worked or when you have serious health problems because of your weight. Some weight-loss procedures limit how much you can eat. Others work by reducing the body's ability to absorb fat and calories. Some procedures do both. Bariatric surgery poses potential health risks, both in the short term and the long term. Bariatric surgery risks can include excessive bleeding, infection, reactions to anaesthesia, blood clots, lung or breathing problems etc. Longer-term risks and complications of weight-loss surgery vary depending on the type of surgery. they can include bowel obstruction, dumping syndrome, a condition that leads to diarrhoea, flushing, light-headedness, nausea or vomiting, gallstones, hernias, hypoglycaemia, malnutrition, ulcers etc.

According to Center for Disease Control and Prevention, in 2022, all U.S. states and territories had an obesity prevalence higher than 20% (more than 1 in 5 adults). Overall, the Midwest (35.8%) and South (35.6%) had the highest prevalence of obesity, followed by the Northeast (30.5%) and West (29.5%). DC had an obesity prevalence between 20% and less than 25%. Therefore, the market is driven by various factors such as rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Medtronic, B. Braun, Conmed Corporation, Johnson & Johnson among others.

Market Dynamics

Market Drivers

Rising obesity rates in US: US has been experiencing a steady increase in obesity rates over the past few decades. According Global Obesity Observatory in US, prevalence of obesity in 2022 was the 41.64%. This trend is likely to continue, creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Increasing awareness of health risks associated with obesity: There's growing public awareness about the serious health complications linked to obesity, including type 2 diabetes, cardiovascular diseases, and certain cancers. This awareness is prompting more individuals to seek effective long-term weight loss solutions, including bariatric surgery.

Technological advancements in bariatric surgery devices: Ongoing innovations in surgical techniques and devices are making bariatric procedures safer, less invasive, and more effective. For example, the development of advanced laparoscopic and robotic-assisted surgical systems is improving surgical outcomes and reducing recovery times.

Market Restraints

High costs associated with bariatric surgeries and devices: Despite improvements in coverage, the high costs of bariatric procedures and devices is still a significant barrier for many patients. This is especially true for those without comprehensive insurance coverage or in provinces with limited public funding for these procedures.

Potential complications and risks of surgical procedures: Like any major surgery, bariatric procedures carry risks such as infection, bleeding, and adverse reactions to anaesthesia. Long-term complications like nutritional deficiencies and dumping syndrome can also occur. These risks may deter some patients from pursuing surgical options.

Limited availability of skilled bariatric surgeons: There's a shortage of surgeons specially trained in bariatric procedures in US, leading to long wait times in some regions. This shortage limits market growth and patient access to these treatments.

Regulatory Landscape and Reimbursement Scenario

Bariatric medical devices are regulated by Health US under the Medical Devices Regulations, which fall under the Food and Drugs Act. These devices are typically classified as Class III or IV, requiring stringent pre-market approval processes including safety and efficacy data submission. Manufacturers must maintain a certified Quality Management System and engage in post-market surveillance. The regulatory framework encompasses device classification, pre-market approval, quality management, post-market surveillance, and advertising regulations. Health US's Medical Devices Bureau oversees the entire process, ensuring devices meet safety, effectiveness, and quality standards before and after market entry.

Reimbursement for bariatric medical devices in US is complex and varies across provinces and territories due to the country's decentralized healthcare system. Generally, bariatric surgery is covered by provincial health insurance plans when deemed medically necessary, but coverage for specific devices can vary. Private insurance plans may offer additional coverage, but this varies by policy. Patients often face long wait times due to limited resources and high demand.

Competitive Landscape

Key Players

Here are some of the major key players in the US Bariatric Surgery Devices Market:

• Medtronic plc.
• Ethicon, Inc. (Johnson & Johnson)
• Olympus Corporation
• Apollo Endosurgery, Inc
• Intuitive Surgical, Inc
• ReShape Lifesciences, Inc
• Allurion Technologies, Inc
• EndoGastric Solutions, Inc
• GI Dynamics, Inc
• Mediflex Surgical Products